DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

Molecular imaging and targeted radiotherapy with radiolabeled cholecystokinin-2 receptor (CCK2R) targeting peptide probes holds high promise to improve the clinical management of patients with metastatic medullary thyroid carcinoma and other CCK2R-expressing malignancies. Low stability and suboptima...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Klingler, Maximilian, Summer, Dominik, Rangger, Christine, Haubner, Roland, Foster, Julie, Sosabowski, Jane, Decristoforo, Clemens, Virgolini, Irene, von Guggenberg, Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2019
Assuntos:
Radiochemistry
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6604694/
https://ncbi.nlm.nih.gov/pubmed/30530828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.221283
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados